Hikma Pharmaceuticals PLC

LSE:HIK Stock Report

Market Cap: UK£3.9b

Hikma Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:HIK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Sep 25BuyUK£224,420Mazen Samih DarwazahIndividual14,000UK£16.03
07 Aug 25BuyUK£3,512,000Mazen Samih DarwazahIndividual200,000UK£17.56
06 Jun 25SellUK£842,000Bassam Wael KanaanIndividual40,000UK£21.05

Insider Trading Volume

Insider Buying: HIK insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HIK?
Owner TypeNumber of SharesOwnership Percentage
State or Government8310.000375%
Public Companies50,0000.0226%
Employee Share Scheme849,3260.384%
Individual Insiders4,854,8182.19%
General Public26,799,56912.1%
Private Companies60,672,66427.4%
Institutions128,224,71857.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.1%
Darhold Ltd.
60,000,000UK£1.1b0%no data
5.76%
BlackRock, Inc.
12,756,157UK£223.6m2.85%no data
3.51%
The Vanguard Group, Inc.
7,779,044UK£136.4m-2.39%no data
3.1%
Bank Julius Bär & Co. AG
6,866,893UK£120.4m5.25%0.39%
2.54%
Boston Partners Global Investors, Inc.
5,630,711UK£98.7m108%0.07%
2.48%
UBS Asset Management AG
5,483,907UK£96.1m0.58%0.01%
1.85%
HSBC Global Asset Management (UK) Limited
4,107,195UK£72.0m28.3%0.04%
1.56%
Royal London Asset Management Ltd.
3,447,085UK£60.4m22.5%0.11%
1.52%
Baillie Gifford & Co.
3,366,940UK£59.0m-14.1%0.03%
1.28%
Amundi Asset Management SAS
2,829,157UK£49.6m3.77%0.01%
1.27%
Columbia Management Investment Advisers, LLC
2,818,222UK£49.4m-4.26%0.01%
1.25%
Polar Capital Holdings Plc
2,762,930UK£48.4m0%0.19%
1.24%
Jupiter Fund Management Plc
2,756,968UK£48.3m40.1%0.16%
1.22%
Invesco Ltd.
2,712,287UK£47.5m-32.7%0.02%
1.19%
Schroder Investment Management Limited
2,634,259UK£46.2m17.8%0.03%
1.04%
Société Générale Société anonyme
2,310,735UK£40.5m-8.5%0.19%
0.98%
State Street Global Advisors, Inc.
2,175,327UK£38.1m-5.74%no data
0.98%
Aviva Investors Global Services Ltd.
2,171,652UK£38.1m765%0.06%
0.92%
Mawer Investment Management Ltd.
2,030,369UK£35.6m-42.6%0.12%
0.84%
Dimensional Fund Advisors LP
1,864,278UK£32.7m2.89%0.01%
0.81%
Fidelity International Ltd
1,793,356UK£31.4m0.74%0.02%
0.77%
AllianceBernstein L.P.
1,699,009UK£29.8m-7.75%0.01%
0.75%
Legal & General Investment Management Limited
1,665,544UK£29.2m-23%0.01%
0.73%
Mazen Samih Darwazah
1,610,837UK£28.2m14.5%no data
0.68%
American Century Investment Management Inc
1,510,772UK£26.5m-9.73%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/24 16:16
End of Day Share Price 2025/10/24 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hikma Pharmaceuticals PLC is covered by 27 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon MatherBarclays
Sidhartha ModiBarclays
Emily FieldBarclays